Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1993-03-29
1994-03-08
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
514269, 514299, 514917, 514 76, 514546, 514663, A61K 4900, A61K 3154, A61K 3144, A61K 31685
Patent
active
052924971
ABSTRACT:
A method of decreasing the toxicity of chemical therapeutic agents administered in cancer chemotherapy including adminstration to a patient undergoing chemotherapy. This reduction in toxicity can be accomplished by administering an effective amount of S-3-(3-methylaminopropylamino)propyl dihydrogen phosphorothioate. Methods of inducing mucolytic activity and reducing toxicity of acetominophen overdose are also discussed. Such activities are induced through the administration of S-3-(3-methylaminopropylamino)propyl dihydrogen phosphorothioate.
REFERENCES:
patent: 3629410 (1971-12-01), Heiffer et al.
patent: 3892824 (1975-07-01), Piper
patent: 4314989 (1982-02-01), Rosen
patent: 4356306 (1982-10-01), Bar et al.
patent: 4424216 (1984-01-01), Cerami et al.
patent: 4510147 (1985-04-01), Bar et al.
patent: 4656034 (1987-04-01), Sarnoff
patent: 4657928 (1987-04-01), Sorenson
patent: 4676979 (1987-06-01), Schellenberg et al.
Furukawa et al., Chem. Abst. 106(9):61084j (1987).
N. F. Tabachnik et al, "Studies on the Reduction of Sputum Viscosity in Cystic Fibrosis Using an Orally Absorbed Protected Thiol," J. Pharmacol. Exp. Ther., vol. 214, No. 2, pp. 246-249, 1980.
F. Valeriote, Ph.D. et al., "Dose and Inteval Relationship for the Interaction of WR-2721 . . . ", International Journal Radiation, Oncology, Biol. Phys., vol. 10, pp. 1561-1564.
F. Valeriote et al., "Protection and Potentiation of Nitrogen Mustard Cytotoxicity by WR-2721", Cancer Research, vol. 42, pp. 4330-4331, 1982.
T. H. Wasserman, M. D. et al., "Differential Protection Against Cytotoxic Chemotherapeutic Effects on Bone Marrow CFUs by WR-2721," Cancer Clinical Trials, vol. 4, pp. 3-6, 1981.
J. M. Yuhas, "Active Versus Passive Absorption Kinetics as the Basis for Selective Protection . . . ," Cancer Research, vol. 40, pp. 1519-1524, 1980.
T. R. Sweeney, "A Survey of Compounds from the Antiradiation Drug Development Program . . . ," Walter Reed Army Institute of Research, Sep. 1979.
Piper James R.
Schein Philip S.
Hook Gregory
U.S. Bioscience, Inc.
Waddell Frederick E.
LandOfFree
Method of reducing chemotherapy toxicity using (methylaminopropy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing chemotherapy toxicity using (methylaminopropy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing chemotherapy toxicity using (methylaminopropy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-151470